Skip to content

Rocket Pharmaceuticals, Inc.

RCKT Nasdaq SEC CIK 1281895

Follow Rocket Pharmaceuticals Weekly email: filings, results, news

News

3 stories filed under Rocket Pharmaceuticals, grouped into ongoing threads

Sells

Thread · 2 stories

Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares

Markets 35 d ago

Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock

Markets 35 d ago 2 sources

More coverage

Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating

Markets 23 d ago 2 sources

Profile

Headquarters: NEW YORK, NY, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator